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Structure and self-association of the Rous sarcoma virus 
capsid protein
Richard L Kingston1†, Tanja Fitzon-Ostendorp1, Elan Zohar Eisenmesser1‡,
Gisela W Schatz2, Volker M Vogt2, Carol Beth Post1,3
and Michael G Rossmann1*
Background: The capsid protein (CA) of retroviruses, such as Rous sarcoma
virus (RSV), consists of two independently folded domains. CA functions as
part of a polyprotein during particle assembly and budding and, in addition,
forms a shell encapsidating the genomic RNA in the mature, infectious virus. 
Results: The structures of the N- and C-terminal domains of RSV CA have
been determined by X-ray crystallography and solution nuclear magnetic
resonance (NMR) spectroscopy, respectively. The N-terminal domain comprises
seven α helices and a short β hairpin at the N terminus. The N-terminal domain
associates through a small, tightly packed, twofold symmetric interface within
the crystal, different from those previously described for other retroviral CAs.
The C-terminal domain is a compact bundle of four α helices, although the last
few residues are disordered. In dilute solution, RSV CA is predominantly
monomeric. We show, however, using electron microscopy, that intact RSV CA
can assemble in vitro to form both tubular structures constructed from toroidal
oligomers and planar monolayers. Both modes of assembly occur under similar
solution conditions, and both sheets and tubes exhibit long-range order.
Conclusions: The tertiary structure of CA is conserved across the major
retroviral genera, yet sequence variations are sufficient to cause change in
associative behavior. CA forms the exterior shell of the viral core in all mature
retroviruses. However, the core morphology differs between viruses. Consistent
with this observation, we find that the capsid proteins of RSV and human
immunodeficiency virus type 1 exhibit different associative behavior in dilute
solution and assemble in vitro into different structures.
Introduction
Rous sarcoma virus (RSV) is a tumor-generating avian
retrovirus. Following its isolation in 1911, it has become
one of the most thoroughly studied retroviruses. These
viruses are dependent on RNA-directed DNA synthesis
for the establishment of infection, via the process of
reverse transcription. They are the causative agents of
cancer and immune disorders in many species. 
All retroviruses possess a gene (gag), which encodes the
major structural proteins of the virion. The gag gene is
translated as a polyprotein, which directs the formation
and release of spherical viral particles. During or after
budding of the virus, the Gag polyprotein is cleaved by the
viral protease, generating the internal structural proteins
found in the infectious retrovirus. These include the pro-
teins MA (matrix), CA (capsid), and NC (nucleocapsid).
Proteolytic cleavage is associated with a structural
rearrangement of the virus, termed maturation. The most
dramatic structural change seen in the maturing retrovirus
is the formation of the viral core, a large assemblage in
which a shell of CA encapsidates the genomic RNA and
the replicative enzymes of the virus. Within the capsid,
NC associates tightly with the RNA, forming a ribonucleo-
protein (RNP) complex, which is the template for reverse
transcription. The retroviral core is delivered into the cyto-
plasm of the host cell during the initial stages of infection.
There has been rapid progress in structural studies of the
individual components of retroviruses (for reviews focused
on human immunodeficiency virus (HIV-1) see [1,2]).
Much less is known about the interaction of these compo-
nents within the virion and the regulation of retroviral
assembly and maturation. This paper focuses on the retro-
viral capsid protein, a molecule comprising two loosely
associated, predominantly α helical domains. Structures of
the nearly full-length capsid protein, or of the individual
domains, have been reported for HIV-1 [3–8], equine
infectious anemia virus (EIAV) [9], and human T-cell
leukemia virus type 1 (HTLV-1) [10]. These results,
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obtained using X-ray crystallography and nuclear magnetic
resonance (NMR) spectroscopy, show that there can be
large variations in the relative positions of the two
domains, with few or no interactions between them
[5,7,9,10]. The C-terminal domain contains the most
highly conserved amino acid sequence within the retro-
viral Gag protein, a stretch of 20 residues termed the
major homology region (MHR). Although the role of this
region is unknown, an essential function in viral replica-
tion is implied by its evolutionary conservation in other-
wise widely diverged sequences. This supposition has
been confirmed by site-directed mutagenesis [11,12]. 
In the immature virion, CA is embedded within the Gag
polyprotein. All immature retroviruses have a similar
supramolecular organization. The Gag proteins are
arranged radially, with the N termini facing the viral
membrane and the C termini in the interior of the parti-
cle. Retroviruses are heterogeneous in size and lack any
overall symmetry [2]. Although CA forms the exterior
shell of the viral core in all mature retroviruses, the core
morphology differs among these viruses. The core in
HIV-1 and other lentiviruses (e.g. EIAV) has a predomi-
nantly conical appearance. The cores of other retro-
viruses, however, such as RSV (cryo-EM unpublished
observations) and murine leukemia virus (MLV), resem-
ble irregular polyhedra. 
The sequence immediately downstream of CA is impor-
tant in directing immature particle formation in RSV and
also during maturation of the virus [13]. The proteolytic
processing that occurs at the C terminus of CA has been
studied in both RSV [14,15] and HIV-1 [16,17]. In both of
these retroviruses, CA is separated from the downstream
NC by a short amino acid sequence, termed the spacer
peptide (SP in RSV, and SP1 or p2 in HIV-1). The spacer
is 12 amino acids long in RSV and 14 amino acids long in
HIV-1 (with some variation among different isolates). In
RSV, deletions of all, or part, of SP do not block particle
assembly or release. All such mutants are non-infectious,
however, with the resulting particles exhibiting increased
size heterogeneity and a reduced stability of the viral core
[13,14]. In HIV-1, most studies have shown that deletions
or point mutations in this region also result in morphologi-
cally aberrant particles of heterogeneous size [16]. Cleav-
age at the N terminus of the spacer peptide is much
slower than cleavage at its C terminus, and an intermedi-
ate species CA SP (CA SP1 in HIV-1) transiently accumu-
lates and disappears during the maturation process [15]. 
We initiated structural studies on RSV CA to help under-
stand the role of CA and the spacer peptide in viral assem-
bly. Crystals of this protein have been described
previously, in which the molecule is arranged in pseudo-
helical fashion [18]. Although the interactions of CA
within these crystals might mimic those found in vivo, the
crystallography is not straightforward, partly because of
crystal disorder. In this paper, we report independent
structure determinations of the two domains of RSV CA;
the N-terminal domain by X-ray crystallography and the
C-terminal domain and spacer peptide by solution NMR
spectroscopy. Results of in vitro assembly studies on
intact CA are also presented.
Results and discussion
The N-terminal domain of RSV CA
Domain structure, the role of the β hairpin, and interactions
within the crystal
X-ray diffraction data were collected to 2.05 Å resolution
from crystals of the N-terminal domain of CA
(residues 1–154) (Table 1). Phases to 2.7 Å resolution
were experimentally determined by multiwavelength
anomalous diffraction (MAD) methods. The crystal space
group is P212121, with two copies of the molecule in the
asymmetric unit. One of the molecules undergoes rela-
tively large displacements from its mean position within
the crystal lattice, and the electron density for this copy is
less resolved. The crystallographic R factors for the final
refined model were 24.7% (Rwork) and 27.1% (Rfree). The
last eight residues of both CA1–154 molecules are disor-
dered and have not been modeled. Comparison with
structures of HIV-1 and EIAV CA [7,9] shows that these
residues form the flexible linker between the two domains
of the intact protein. 
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Table 1
X-ray diffraction data and model refinement statistics: 
N-terminal domain of RSV CA.
Data set Native MAD
X-ray diffraction data
X-ray source APS 14-BM-c APS 14-BM-d
Outer resolution limit (Å) 2.05 2.70
Redundancy 5.0 (4.7)* 4.0
Completeness (%) 92.5 (89.8)* 98
Rmeasure 0.049 (0.335)*
peak 1 0.037/0.056†
peak 2 0.034/0.064†
inflexion 1 0.036/0.038†
inflexion 2 0.035/0.046†
remote 0.034/0.048†
Model refinement
Rwork/Rfree 24.7/27.1
Missing regions
molecule 1/molecule 2 None/6–8, 96–98
Mean B values
molecule 1/molecule 2 (Å2) 36/49
Number of water molecules 101
Rmsd from ideal 
bond lengths (Å) 0.005
bond angles (°) 1.1
Ramachandran plot
residues in most favored regions (%) 94
*Statistics for highest resolution bin (2.11–2.05 Å) in parentheses.
†Centric/acentric observations. 
The N-terminal domain comprises seven α helices,
together with a short β hairpin at the N terminus, and is
similar to that found in other retroviral CAs (Figure 1).
The least conserved region within CA is found between
the fourth and last helices of the domain (the top left of
the molecule in Figure 1), where corresponding helices
vary significantly in both length and orientation in the four
known structures (RSV, HIV-1, HTLV-1, EIAV). This
region encompasses the flexible, proline-rich, cyclophilin-
A binding loop found in HIV-1 CA. 
The β hairpin in RSV CA (amino acids 1–12) projects
away from the main body of the domain and is anchored in
place at the N terminus by a salt bridge between the
charged N-terminal proline residue and a buried aspartic
acid (Figure 1). In this, it closely resembles HIV-1 CA, in
which the hairpin (amino acids 1–13) is held in place by
equivalent interactions [3–5]. In the better defined copy
of RSV CA1–154, the electron density for the β hairpin is
readily interpretable. In the second copy of this molecule,
there is no interpretable electron density for amino acids
6–8, the most distal part of the hairpin. This structural
element seems to be quite mobile in both RSV and HIV-1
[3,4,19]. The conservation of the β hairpin among retrovi-
ral CAs has been widely anticipated; however, RSV is only
the second retrovirus in which this has been experimen-
tally demonstrated. In structure determinations of EIAV
and HTLV-1 CA [9,10], the molecules studied did not
have wild-type sequences at the N terminus, and the
structure of this region was not resolved.
The N-terminal β hairpin, as seen in RSV and HIV-1 CA,
can only completely form after proteolysis of the Gag pre-
cursor. In HIV-1, it was proposed, largely on the basis of
crystallographic results [3], that structural rearrangement
at the N terminus following proteolysis allows formation
of a new CA–CA interface, facilitating assembly of the
capsid in the maturing virus [3,4]. The N-terminal proline,
and its bonding partner (aspartic acid or glutamic acid), are
conserved among highly diverged retroviral sequences,
suggesting that similar events occur in almost all retro-
viruses. Hence, it was hypothesized that the N terminus
of CA functioned as a ‘conformational switch’ responsible
for redirecting assembly of CA in the mature virion. This
concept is supported by the in vitro assembly studies on
purified viral components, although results for HIV-1 [20]
and RSV [21] were not entirely consistent. The recent
observation that truncated HIV-1 Gag proteins with an
‘immature’ CA N terminus can be assembled into either
tubes (resembling the mature core) or spheres (resembling
the immature virion), depending upon solution pH [22],
indicates that the switching hypothesis is probably over-
simplified. It is not clear to what extent the structure at
the N terminus of mature CA is formed within the Gag
polyprotein. The β hairpin must be at least transiently dis-
rupted to allow access to the viral protease and, hence,
must fold in a semi-autonomous fashion. The N-terminal
proline in RSV is followed in the sequence by three
β-branched amino acids (Val–Val–Ile), which have a high
intrinsic propensity for β sheet formation [23]. This might
help direct the formation and stabilization of the hairpin.
More generally, there is a strong preference for
β-branched amino acids at positions 2 and 3 in the
sequences of all retroviral CAs. 
The two noncrystallographically related copies of the
protein interact through a tightly packed interface, arising
from the parallel association of the fourth helix of the
domain (Figure 2). The interface exhibits almost perfect
twofold rotational symmetry (the two molecules involved
are related by a rotation of 178°, with a translation of 0.2 Å
along the symmetry axis). Residues at the core of the inter-
face are hydrophobic, but the area of interaction is small,
with the molecular surface area of each of the interacting
domains reduced by only 1.9% (250 Å2). The domain inter-
action is mediated by an octahedrally coordinated metal
ion (probably Mg2+, which was present at high concentra-
tion in the crystallization medium). The metal ion is bound
to Asp71 in each molecule and to four coplanar water mol-
ecules. This interface is different from the twofold sym-
metric interfaces previously reported for the N-terminal
domain of HIV-1 CA in complex with a monoclonal anti-
body fragment [5] or with cyclophilin A [3]. The N-termi-
nal β hairpin is found on the exterior of the complex and is
not involved in interface formation (Figure 2). This inter-
face could be one of several interactions involved in assem-
bly of the immature or mature particle.
The C-terminal domain of RSV CA
Structure determination by NMR spectroscopy
We overexpressed two constructs in Escherichia coli,
encompassing the C-terminal domain of CA, and studied
them by solution NMR spectroscopy. Both start at residue
155 of CA and contain, in addition to the wild-type
sequence, an initiating methionine. Evaluation of the
probable domain boundary was made on the basis of prote-
olysis experiments on HIV-1 CA [4], coupled with align-
ment of the HIV-1 and RSV CA sequences. Recent
structural studies suggest that the flexible polypeptide
linking the N- and C-terminal domains begins several
residues upstream [7,9,10]. The first construct (CA155–237)
ends at Ala237, which is the C terminus of the predomi-
nant variant of mature RSV CA [15]. The second construct
(CA155–249) ends at Met249, hence including both the
C-terminal domain of CA and the spacer peptide. The
constructs show no apparent self-association in dilute solu-
tion, as monitored by size-exclusion chromatography (data
not shown). This is consistent with results for the intact
protein, which behaves in a similar fashion (see below).
The four α helices of the C-terminal domain were readily
identified by analysis of their chemical shifts [24] and by
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characteristic patterns of short and medium range nuclear
Overhauser enhancements (NOEs). The final helix termi-
nates at Arg225. In both the shorter and longer constructs,
there are no significant chemical shift deviations from
random coil values beyond Pro230. Addition of the spacer
peptide to the C terminus of CA slightly perturbs the
NMR chemical shifts of the last seven residues (amino
acids 230–237) and results in chemical shift heterogeneity,
beginning at Pro230. Instead of a single resonance associ-
ated with each nucleus, more than one was often
observed, although they all clustered around random coil
values. The chemical shift heterogeneity is most probably
because of cis–trans isomerization of Pro230 and Pro246.
There is an almost complete absence of inter-residual
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Figure 1
The N-terminal domain of the retroviral capsid
protein. (a) RSV, (b) HIV-1. The β hairpin is
shown in detail, in an orientation that is slightly
different from that of the whole domain. The
boundaries of the helices within the N-terminal
domain of RSV CA are: helix 1, 15–30; 2,
33–44; 3, 49–61; 4, 62–87; 5, 102–107; 6,
116–124; 7, 125–147. Helix definitions
incorporate the N- and C-terminal capping
residues. Coordinates for the N-terminal
domain of HIV-1 CA were taken from the X-ray
structure of the molecule in complex with
cyclophilin A [3]. The program Ribbons 2.0
[50] was used in the preparation of the figure.
NOEs in the region C-terminal to Pro230, whether or not
the spacer peptide is present.
The magnitudes of the steady-state heteronuclear 1H–15N
NOEs were measured to study the mainchain flexibility.
The steady-state 1H–15N NOE is highly sensitive to reori-
entation of the 1H–15N bond vector, with negative, or
small positive, NOE values being indicative of fast motion
relative to the overall tumbling rate of the molecule. In the
shorter construct, the heteronuclear NOEs for the back-
bone amide groups start to decrease sharply at Arg225, and
beyond residue 230 they become negative. The same
pattern is exhibited in the longer construct with none of
the residues in the spacer peptide exhibiting large positive
heteronuclear NOEs. These results indicate that the C
terminus of CA and the spacer peptide (residues 230–249)
do not possess any persistent secondary or tertiary struc-
ture and are flexible in solution. Deletion of the spacer
peptide results in no detectable change within the struc-
tured region of the C-terminal domain.
Solution structure of the C-terminal domain
The three-dimensional structure of the C-terminal
domain (residues 155–230) was determined from NOE-
derived distance restraints, together with 3-bond J-cou-
pling measurements and chemical shift data (see the
Materials and methods section). The minimized average
structure agrees well with the experimental restraints
(Table 2) and has 88% of the amino acids in the most
favored region of the Ramachandran plot. 
The four α helices of the C-terminal domain form a
compact bundle (Figure 3). The N-terminal residues
(155–159) have an extended conformation and pack against
the first helix of the domain. The MHR encompasses this
N-terminal extended strand, the subsequent β turn and
much of the first helix. Several of the invariantly conserved
amino acids within the MHR are involved in formation of
the β turn. Critical to the integrity of this region is a gluta-
mine residue (Gln158 in RSV) that functions as a hydro-
gen-bond donor and acceptor, bridging the N terminus of
helix 1 and the C terminus of helix 2. All tested mutations
of this residue in RSV disrupt particle assembly and
abolish viral replication [12] (T Cairns and R Craven,
unpublished observations). A conservative substitution of
the equivalent residue in HIV-1 has a similar effect [11].
Most other elements of the associated hydrogen bonding
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Figure 2
The twofold symmetric interaction between CA1–154 molecules seen
within the crystal. (a) The interaction involves the parallel packing of
helix 4 from adjacent molecules. Although the distal part of the
β hairpin and one of the surface loops are not completely ordered in
one copy of the molecule, this is not shown. (b) Details of the
interface. The sidechain atoms Ala64, Ala67, Leu68 and Asp71 are
shown in ball-and-stick representation. Asp71 in both molecules is
coordinated to a bridging metal ion, most likely Mg2+. The program
Ribbons 2.0 [50] was used in the preparation of the figure. 
Table 2
Structure calculation statistics: C-terminal domain of RSV CA.
NOE-derived distance restraints*
Ambiguous 460
Unambiguous 1323
Intraresidue (|i–j | = 0) 647
Sequential (|i—j | = 1) 333
Medium range (1 < |i—j | < 5) 239
Long range ( | i—j | ≥ 5) 104
J-coupling restraints
3J(HN,Hα) (ϕ) 59/3†
3J(N,Hβ) (χ*) 16/21†
Precision of structural ensemble (19 structures)
Rmsd from minimized average structure
All atoms: residues 155–225 (Å) 1.53
Cα atoms: residues 155–225 (Å) 0.86
Agreement of structures with restraints‡
Distance restraint violations 0
J-coupling restraints (Hz) 0.628§
Chemical shifts
Cα (ppm) 1.114§
Cβ (ppm) 1.494§
Non-amide proton chemical shifts (ppm) 0.324§
*Restraint lists were not edited to remove structurally insignificant
restraints. †Achiral groups/prochiral groups. ‡Mean value for ensemble.
§Rmsd between experimental values and values calculated from the
NMR structures. 
network within HIV-1 [6] are present in RSV. It has not
been possible to fully define the sidechain conformation of
Arg170, which is completely conserved among CA
sequences. Nonetheless, there are several indications that
this residue adopts a fixed position within the structure
(see Materials and methods). The hydrophobic residues
within the MHR are found on the interior face of the first
helix. Given the potential for compensatory mutations
within the hydrophobic core of most proteins, the reason
for their conservation remains uncertain.
The spacer peptide appears unstructured: implications for
assembly and maturation
The lack of persistent structure at the C terminus of RSV
CA and within the spacer peptide is consistent with
studies on other retroviral CAs. The last 8–10 amino acids
of the HIV-1 and EIAV CAs are disordered in X-ray
crystal structures [6–9], and NMR spectroscopy shows that
this region lacks structure in HTLV-1 CA [10]. For HIV-1,
one of the proteins studied encompassed both the C-ter-
minal domain and the spacer peptide SP1 [8]; however,
SP1 was found to be disordered within the crystal.
Although a helix overlapping the CA SP1 boundary in
HIV-1 has been predicted [16], no direct experimental
evidence exists in support of this hypothesis.
It is unclear if these observations can be related directly to
the situation in vivo. Proteolytic cleavage might be associ-
ated with conformational change, thereby causing the
structure of the mature proteins, or transiently observed
intermediates, to differ from that embedded in the
polyprotein precursor. Within the immature virus, lateral
interactions between the Gag polyprotein, mediated by
nucleic acid binding, will confine the polypeptide chain at
the CA–NC boundary to a very restricted volume, poten-
tially influencing structure in this region. Nevertheless,
there is little evidence to suggest that the spacer peptide
needs to be structured to fulfill its role in viral assembly
and maturation. The assembly of immature particles is a
robust process, and the Gag polyprotein in some retro-
viruses is known to include domains that are unstructured
in vitro [1]. During maturation, the removal of the spacer
peptide from the C terminus of CA appears essential for
proper condensation of CA around the RNP complex in
RSV and HIV-1 [14,16,17]. The presence of a long, flexi-
ble extension at the C terminus of CA, however, could
block capsid assembly through a simple steric mechanism. 
The majority of retroviruses possess a spacer peptide
which separates mature CA and NC; however, it varies
widely in length and composition, ranging from five amino
acids in EIAV to 25 amino acids in bovine immunodefi-
ciency virus (BIV). In several retroviruses (RSV, HIV-1,
BIV), there are multiple cleavage sites within the spacer
peptide. Some retroviruses (mouse mammary tumor virus
(MMTV) and MLV) lack a spacer peptide altogether. It,
therefore, seems unlikely that the spacer peptide has a
completely defined and invariant structure in HIV-1 or in
any other retrovirus.
Intermolecular association and the C-terminal domain 
Structures of retroviral CAs have not fully clarified the
pathway or outcome of viral assembly. The CA–CA
interactions within the immature and mature virus might
be quite different, as suggested, for example, by
crosslinking studies on MLV [25]. The study of capsid
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Figure 3
A stereo-diagram showing 19 conformers
representing the solution structure of the
C-terminal domain of RSV CA. Only the
backbone atoms (N, C, Cα) are displayed.
The boundaries of the helices within the
C-terminal domain of RSV CA are: helix 1,
163–177; 2, 181–197; 3, 198–208; 4,
214–226. Helix definitions incorporate the 
N- and C-terminal capping residues. The
program Molscript [51] was used in the
preparation of the figure.
N
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condensation in the maturing virus is further compli-
cated by the transitory nature of the interactions
involved, the potential for cooperative association of the
two flexibly linked domains of CA, and the irregularity of
the authentic viral core. 
The C-terminal domain of HIV-1 CA (the ‘dimerization
domain’ [6,8]) is responsible for the self-association of this
protein in dilute solution. The X-ray crystal structure of
the C-terminal domain of HIV-1 CA shows that the dimer
interface is built around the parallel packing of helix 2
across a twofold rotation axis [6,8]. A similar, but not iden-
tical, interaction is seen in a crystal structure of EIAV CA
[9]. This dimer might be an intermediate in the capsid
assembly pathway, such as occur during assembly of some
icosahedral viruses. 
The molecular surface of the C-terminal domain of CA is
displayed for RSV, and for three other retroviruses, in
Figure 4. On the front face of the domain (Figure 4a), a
hydrophobic surface patch associated with the N terminus
of helix 2 is relatively conserved, consistent with its persis-
tent involvement in the domain interactions seen crystal-
lographically [6–9]. On the reverse face of the domain
(Figure 4b), there is another hydrophobic surface patch,
which is of largest extent in RSV. The predominant con-
tribution to this region is made by residues within the first
and fourth helices of the domain, and its size suggests that
it could be involved in intermolecular association.
Although the burial of nonpolar residues might drive
protein–protein association, the complementarity of the
interacting regions will dictate the specific result. Chang-
ing the solution pH can profoundly affect the outcome of
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Figure 4
Surface properties of the C-terminal domain.
(a) Schematic representation of the C-terminal
domains of four retroviral CAs (top).
Corresponding representations of the
molecular surface (bottom). Regions of the
molecular surface arising from non-polar
amino acids (G,A,P,V,I,L,F,M,C,W [52]) are
colored blue. (b) This figure displays the same
information as in (a) but the domains have
been rotated by 180° so that the reverse face
of the molecule is visible. For clarity, the N
terminus has been truncated at an equivalent
point in each structure (Asp155 in RSV,
Asp152 in HIV-1, Asn152 in EIAV, Ser135 in
HTLV-1). Several residues N-terminal to this
position should be considered part of the
C-terminal domain and are potentially involved
in domain association [6,8]. Ribbon diagrams
were prepared using the program Ribbons 2.0
[50], and molecular surfaces were calculated
and displayed using the programs MSMS and
MSV [53]. Vertices of the triangulated surface
were colored by the property of the closest
atom. The Protein Data Bank accession codes
of the structural models used to generate the
figure are 1a43 (HIV-1 [8]), 1eia (EIAV [9]),
1qrj (HTLV-1 [10]).
in vitro assembly studies on purified retroviral components
[21,22], and, hence, the protonation state of individual
amino acids might be critical to assembly.
Self-association of intact RSV CA
In vitro assembly of RSV CA into regular structures
Size-exclusion chromatography was used to characterize
the behavior of intact RSV CA in dilute solution. Protein
concentrations up to 780 µm were studied, at near neutral
pH, with no change in behavior observed under reducing
or oxidizing conditions. Purified CA eluted in a single
peak, at a position consistent with a monomeric associative
state. As expected for a monomeric species, the elution
time did not depend on the concentration of the protein
loaded onto the column. An N-terminally truncated
HTLV-1 CA is also monomeric at concentrations up to
1000 µm [10]. In contrast, HIV-1 CA dimerizes with an
equilibrium dissociation constant Kd = 10–30 µM, with
dimerization apparently mediated by the C-terminal
domain alone [6]. 
The structures of the two independently folded domains
of RSV CA, and the behavior of CA in dilute solution [11],
give few indications how the molecule might interact to
form higher-order structures. Consequently, transmission
electron microscopy (TEM) was used to study the in vitro
assembly of CA. Intact CA (2–10 mg/ml) assembles into
regular structures at mildly acidic pH, in the presence of
0.6–1.1 M NaCl. The in vitro assembly of HIV-1 CA to
form tubular structures occurs under similar conditions
[26,27]. At these concentrations, the salt acts to reduce
protein solubility. 
Two types of higher-order assembly were observed at such
conditions (Figure 5). Most commonly, large planar arrays
formed, spanning thousands of nanometers. The edges of
these arrays are often curled up to form partially closed
tubes with a varying external diameter of ~90 nm. The
planar sheets were ordered, with Fourier transformation of
images giving rise to discrete peaks, arranged on a regular
lattice. The diffraction pattern can be indexed on a hexag-
onal lattice (approximate cell dimensions a = b = 9.1 nm,
γ = 60°) or, alternatively, on a ‘centered’ rectangular lattice
(approximate cell dimensions a = 9.0 nm, b = 15.9 nm,
γ = 90°). Diffraction from well-preserved negatively
stained arrays extends to approximately 25 Å resolution.
Filtered images of untilted, negatively stained arrays
possess approximate C2mm plane group symmetry. This
would arise in projection if the layer group of the crystal
was C222. This tentative layer group assignment implies
that there are twofold symmetric interfaces that mediate
the formation of the array.
The second mode of RSV CA assembly was observed
more sporadically. In this case, the CA assembled into
toroidal oligomers (mean diameter ~20 nm), possessing a
stain-accessible central cavity (Figure 5). Neither mode of
assembly described for RSV CA can exactly represent the
situation within the virion, however, because the authen-
tic viral core is a closed, irregular structure, that lacks a
fixed geometry.
Comparison with previous results
The in vitro assembly of HIV-1 CA protein into tubular
structures has been reported previously [26–28]. These
tubes have a variable diameter of 40–50 nm and exhibit
long-range order [28,29]. They appear to have a layered
architecture, with the N-terminal domain on the outside
of the cylinder and the C-terminal domain on the inside
[28]. Morphologically similar tubes can be assembled from
CA–NC fusion proteins in the presence of nucleic acids.
Under suitable solution conditions, these tubes close off
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Figure 5
Two discrete modes of assembly for RSV CA. (a) TEM image of part
of a planar array of RSV CA, negatively stained with uranyl acetate. The
planar array curls up, forming partially closed tubular structures, at the
sheet boundaries (indicated with dark arrows). (b) TEM image of tubes
of RSV CA, apparently formed from a toroidal oligomer. The specimen
has been negatively stained with uranyl acetate. Free oligomers are
indicated with dark arrows.
into conical structures that closely resemble the mature
core of HIV-1 [22,29]. Similarities in the helical diffraction
patterns of the tubular structures, and the viral core,
suggest similarities in their internal organization [2]. Thus,
for HIV-1 there are clear parallels between the structures
assembled in vitro and in vivo. 
In this paper, two additional modes of assembly have been
identified for RSV CA alone. Neither of the resulting
structures appears macroscopically similar to the tubes of
HIV-1 CA. The planar sheets of RSV CA have rectangular
symmetry (tentative layer group assignment C222),
whereas HIV-1 CA tubes reportedly possess hexagonal
symmetry [29]. The tubular structures of RSV CA, built
up from toroidal oligomers, are also dissimilar to the thin-
walled hollow tubes of HIV-1 CA. 
Biological implications
Rous sarcoma virus (RSV) is a tumorigenic avian retro-
virus. The emergence of the related human immunodefi-
ciency virus (HIV-1), and the resulting world-wide
autoimmunodeficiency syndrome (AIDS) pandemic,
has lent a new urgency to the study of such infectious
agents. The RSV capsid protein (CA), like all the inter-
nal structural proteins of the virus, is first expressed as
part of a polyprotein and is later liberated by the viral
protease. CA forms the exterior shell of the viral core,
which is delivered into the host cell in the initial stages of
infection. The core in RSV resembles an irregular poly-
hedron, differing from the conical appearance of the
core in lentiviruses, such as HIV-1. Despite knowledge
of the three-dimensional structures of many retroviral
components, the understanding of core architecture and
assembly is rudimentary. 
The structures of the N- and C-terminal domains of RSV
CA are presented in this paper and are found to closely
resemble those described for other retroviruses. Along
with HIV-1, RSV is one of the best characterized mol-
ecular genetic systems for the study of retroviruses.
Structures of the two domains of CA will be of great
importance in interpreting phenotypes resulting from
mutagenesis. In common with HIV-1, the N terminus of
RSV CA forms a β hairpin, anchored in place by an
internal salt bridge. Given that refolding of the N termi-
nus following proteolysis might help direct capsid assem-
bly in the maturing virus, the conservation of this
structure across retroviral families is significant and has
not been demonstrated previously. The N-terminal
domain associates through a twofold symmetric interface
within the crystal that does not directly involve the β
hairpin. 
In vitro assembly studies of intact RSV CA are also
presented. The molecule is shown to form both tubes,
constructed from a toroidal oligomer, and flat sheets.
Both modes of assembly occur at mildly acidic pH in
the presence of moderate salt concentrations. Image
analysis of the planar sheets, which are the predomi-
nant assembly product, suggests that twofold symmetric
interactions between domains mediate the formation of
this structure. Although the in vitro assembly of HIV-1
CA into tubular structures has been reported previ-
ously, these do not macroscopically resemble the sheets
or tubes of RSV CA. With in vitro assembly systems for
both HIV-1 and RSV CA now described, it might be
possible to understand the origin and significance of the
different core morphologies of these retroviruses.
Materials and methods
Structure determination of the N-terminal domain of RSV CA
Protein expression, purification and crystallization
DNA encoding the selected region of the RSV Gag protein (Prague
strain C) [30] was amplified using the polymerase chain reaction, sub-
cloned into the pET 3xc expression vector (Novagen), and transformed
into the BL21 (DE3) pLysS strain of E. coli (Novagen). The expressed
protein (CA1–154) comprises the first 154 amino acids of mature CA
and has a molecular weight of 16,480 Da.
The transformed cells were grown at 37°C in 2YT media, supple-
mented with ampicillin (100 µg/ml) and chloramphenicol (34 µg/ml).
Protein expression was induced by addition of isopropyl-β-D-thiogalac-
topyranoside (IPTG), and the cells harvested 4–5 h after induction.
Cells were lysed using a French press. The crude cell lysate was sus-
pended in 20 mM Tris/HCl buffer pH 8.0, containing 50 mM NaCl,
1 mM EDTA, 1 mM DTT, and 1 mM PMSF. Protamine sulfate (final con-
centration 10 mg/ml) was added to precipitate nucleic acids. Following
centrifugation, CA1–154 was purified from the supernatant by size-exclu-
sion chromatography. Superdex 75 preparation and analytical grade
columns (Pharmacia) were used sequentially. 
Selenomethionine-substituted protein was produced by down-regula-
tion of methionine biosynthesis, using the same vector and host strain.
Cells were grown in 2YT media until ready for induction. The cells were
spun down, washed, and resuspended in M9 minimal media, supple-
mented with lysine, threonine, valine, phenylalanine, leucine and
isoleucine, all at 100 µg/ml, and selenomethionine at 50 µg/ml. After
30 min growth, the cells were induced and harvested 4–5 h later. The
incorporation of selenomethionine was confirmed using matrix-associ-
ated laser desorption ionisation (MALDI) mass spectrometry.
Crystals of CA1–154 were grown by vapor diffusion methods. Crystal-
lization conditions were identified using experiments based on orthogo-
nal arrays [31]. The protein (20–30 mg/ml in 20 mM Tris/HCL buffer,
pH 8.0, 50 mM NaCl) was equilibrated at 4°C, against a reservoir solu-
tion containing 0.15 M Boric acid/KOH buffer, pH 9.1, 16–22% (w/v)
PEG 6000, and 0.7 M Mg(NO3)2. It was necessary to use seeding pro-
cedures to obtain crystals of a useful size. Crystals of the selenome-
thionine-substituted protein were prepared in the same fashion. In the
latter case, however, it was necessary to include the reducing agent
Tris-carboxy ethyl phosphine (TCEP) at a concentration of 1–5 mM in
order to prevent protein oxidation. Concentrations of all proteins
studied in this paper were measured by spectrophotometric methods.
Crystals were transferred to a cryoprotective solution (0.15 M Boric
acid/KOH buffer, pH 9.1, 24% (w/v) PEG 6000, 0.7 M Mg(NO3)2,
15% (v/v) ethylene glycol) and flash frozen in a cold gas stream for
X-ray data collection. All diffraction data were collected at 113K.
Data integration and scaling were performed with the programs
Denzo and Scalepack [32].
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A native data set, which was used for the refinement of the structural
model, was collected from a single frozen crystal at the Advanced
Photon Source (APS) in Argonne, Illinois (station 14-BM-c) (Table 1).
The crystal space group is P212121, with cell dimensions a = 40.5 Å,
b = 64.5 Å, c = 108.9 Å. There are two molecules in the asymmetric
unit of the crystal, related by an almost perfect twofold rotation. The
Matthews coefficient, VM, is 2.16 Å3/Da, which corresponds to a
solvent content of ~43%. Bragg diffraction from the crystals extends to
approximately 2.0 Å resolution, but falls off in an anisotropic fashion. 
Crystallographic phase determination by MAD
To phase the X-ray diffraction data, a MAD experiment, based on the
selenium K-edge, was carried out at the APS (station 14-BM-d). Data
were collected at five wavelengths, four of which were close to the
X-ray absorption edge (Table 1). The inverse beam method was used
to accumulate the Friedel pairs at each wavelength. Data collected at
each wavelength were put on the same relative scale using the
program FHSCAL [33]. Estimates for |FA|, the structure factor ampli-
tudes of the anomalously scattering selenium atoms, were derived
using an algebraic procedure (RLK, unpublished observations). Direct
methods coupled with phase annealing [34] were used to locate nine
of ten selenium atoms. Phases were calculated and refined using the
program MLPHARE [35]. This yielded a readily interpretable map,
which was further improved using solvent flattening and histogram
matching with the program DM [36].
Model building and refinement
The program Xfit from the XTALVIEW software package [37] was used
for interactive model building. The model was refined with the program
CNS [38], using torsion angle molecular dynamics procedures that
incorporate a maximum-likelihood target function. Atomic displace-
ments were modeled with an isotropic B value for each atom, with
restraints on the B values of neighboring atoms. The contribution of the
bulk solvent to the X-ray diffraction was modeled using a flat masking
procedure [39]. No noncrystallographic symmetry restraints or con-
straints were applied during refinement. Five percent of the observed
data was randomly selected for calculation of Rfree and excluded from
all refinement procedures. Statistics associated with the final refined
model are presented in Table 1.
Structure determination of the C-terminal domain of RSV CA
Sample preparation
The two proteins encompassing the C-terminal domain of CA were
expressed from cloned DNA segments as described for the N-terminal
domain. One of the expressed proteins (CA155–237 ) comprises the last
83 amino acids of CA, plus an initiating methionine at the N terminus,
and has a molecular weight of 9212 Da. A second protein (CA155–249)
contains, in addition, the 12 amino acid spacer peptide and has a mol-
ecular weight of 9485 Da.
Uniformly 15N- and 15N/13C-labeled proteins were prepared by growing
the cells in M9 minimal media, containing 15NH4Cl (1 g/l) and 12C6-D-
glucose (2 g/l) or 15NH4Cl (1 g/l) and 13C6-D-glucose (2 g/l), respec-
tively, supplemented with ampicillin (100 µg/ml) and chloramphenicol
(34 µg/ml). Protein expression was induced late in log phase growth
(A600 ~0.7) by addition of IPTG. The cells were harvested 4 h after
induction and lysed either by freeze-thaw cycling or using a French
press. The crude cell lysate was suspended in 50 mM sodium phos-
phate buffer, pH 7.5, containing 50 mM NaCl, 1 mM EDTA, and 1 mM
dithiothreitol. Protamine sulfate (final concentration 10 mg/ml) was
added to precipitate nucleic acids. Following centrifugation, the RSV
CA fragments were purified from the supernatant by size-exclusion
chromatography. Superdex 200 and Superdex 75 columns (Pharma-
cia) were used in sequence. Purified proteins were concentrated to
10–20 mg/ml in 50 mM sodium phosphate buffer, pH 4.9, containing
50 mM NaCl, 1 mM EDTA, and 1 mM deuterated dithiothreitol. 10%
(v/v) 2H20 was added to the samples before NMR data acquisition.
NMR spectroscopy and data processing
All spectra were recorded at 25°C on a Varian UnityPlus 600 MHz spec-
trometer, equipped with a z-shielded gradient triple-resonance probe.
NMR data were analyzed with the programs NMRPipe [40] and ANSIG
[41]. 1H chemical shifts are reported relative to DSS. 13C and 15N chem-
ical shifts were referenced indirectly using standard frequency ratios.
Steady-state heteronuclear 1H–15N NOEs were measured using the
pulse sequences of Farrow et al. [42], with and without proton satura-
tion. Approximate error estimates were derived from the intensity varia-
tion in background regions [42].
Spectral assignments
Sequential backbone assignments were made using a combination of
15N-resolved [1H,1H]-NOESY, HNHA, HNHB77, and J-correlation experi-
ments (CBCANH, CBCACONH). Assignments of sidechain nuclei were
made using a combination of J-correlation experiments (H(CCO)NH,
C(CO)NH) and NOE-based approaches. Complete 1H, 15N and 13C
chemical shift assignment was achieved for residues 155–230 of the
C-terminal domain. Stereospecific assignments have not been made.
Chemical shift assignment within the unstructured C-terminal region
(231–249) was complicated by chemical shift heterogeneity, resonance
overlap, and limited NOE information. Partial assignments, including
most of the backbone nuclei, have been made for this region.
Determination of conformational constraints
Distance restraints for the calculation of the 3D structure were derived
from 13C- or 15N-resolved [1H,1H]-NOESY spectra (mixing time
150 ms). Distances (D) were estimated using the isolated spin pair
approximation, Dij —6 = AIij, where A is a calibration factor determined
using known distances within the α helices (Hα(i) → HN(i+3) ~3.4 Å).
Upper (U) and lower (L) bounds for the structure calculation were then
set to L = D — 0.12D2, U = D + 0.12D2 [43]. Ambiguous and degener-
ate NOE crosspeaks were treated using `r—6 summation’. The 3J(HN,Hα)
and 3J(N,Hβ) coupling constants were derived from the HNHA and
HNHB experiments, respectively [44]. Only the longer construct
(CA155–249) was isotopically enriched with both 15N and 13C, and
restraints used in the structure calculation were derived from spectra
recorded on this protein. 
Calculation of the three-dimensional structure
Starting from an extended strand conformation, structures were calcu-
lated using torsion angle dynamics with the program CNS [38]. NOE-
derived distances were restrained by a flat-bottomed parabolic function
and a simplified repulsive function describing the van der Waals inter-
actions. Restraints on backbone φ and ψ torsion angles were incorpo-
rated using an empirical relationship between these quantities and the
13Cα and 13Cβ chemical shifts [45]. Direct refinement against vicinal
scalar coupling constants was employed [46,47], with Karplus parame-
ters relating coupling constants to torsion angles. Restraints based on
1H chemical shifts were included for the non-amide protons [48].
For the final calculation, 100 structures were generated using torsion
angle molecular dynamics. On the basis of agreement with the experi-
mental restraints and geometric ideality 19 these structures were
accepted (Figure 3). A mean structure was calculated from this ensem-
ble and regularized by restrained energy minimization. Statistics associ-
ated with the final structure calculation are shown in Table 2. 
Structure validation
The final model has 88% of the residues in the core region of the
Ramachandran plot and the remainder (excepting Ser210) in the
additional allowed regions (defined by the program PROCHECK).
Ser210 is found in a poorly restrained surface loop connecting
helices 3 and 4 of the domain (Figure 3). The final model contains no
highly improbable sidechain χ1,χ2 choices [49]. It was also verified
that most short interproton distances predicted by the model had cor-
responding NOE crosspeaks. 
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Arg170, which is an invariantly conserved residue within the MHR of
the C-terminal domain, is poorly defined in the current model. Few
NOE interactions were observed for the distal region of this sidechain,
with exchangeable Hη protons. However, there are several indications
that this residue actually adopts a fixed position within the structure.
Firstly, the steady-state 1Hε–15Nε NOE is positive, with a magnitude
(0.63) that is only slightly smaller than the backbone 1H–15N NOEs. In
comparison, the 1Hε–15Nε NOEs for the other four arginine residues in
the C-terminal domain (Arg185, Arg194, Arg206 and Arg225) are less
than 0.08. Secondly, the sidechain Hε of Arg170 experiences a strong
downfield shift, resonating at 9.86 ppm (cf. the random coil chemical
shift of 8.06 ppm), consistent with the involvement of this residue in a
strong hydrogen-bonding network. Finally, a weak NOE crosspeak can
be identified between Hε of Arg170 and Hα of either residue 166 or
167. This localizes the sidechain to the same region it occupies in the
crystallographic structures of HIV-1 and EIAV CA [6,8,9]. 
Self-association of RSV CA
Behavior of the CA in dilute solution
Bacterial overexpression and purification of intact RSV CA has been
described previously [18]. The behavior of the protein in dilute solution
was studied by size-exclusion chromatography on a Superdex 75 column
(Pharmacia). The protein was suspended in 25 mM EPPS/NaOH buffer,
pH 8.0, containing 1 mM EDTA and 50 mM NaCl. The redox potential of
the solution was controlled by including reduced and oxidized glu-
tathione. Column runs were performed under both reducing (5.0 mM oxi-
dized glutathione, 0.5 mM reduced glutathione) and oxidizing (0.5 mM
oxidized glutathione, 5.0 mM reduced glutathione) conditions, with
protein loading concentrations between 1 and 20 mg/ml. 
Assembly of CA into higher order structures
Self-assembly of CA was studied using both vapor-diffusion and equilib-
rium dialysis techniques. In general, sitting-drop vapor-diffusion methods
gave the most reproducible results. CA (2–10 mg/ml in 20 mM Tris/HCl
buffer, pH 7.5, 1 mM EDTA, 50 mM NaCl) was equilibrated against NaCl
solutions buffered at varying pH. To monitor assembly, the samples were
applied to glow-discharged carbon/formvar-coated electron microscopy
grids. Excess liquid was removed by blotting. The samples were stained
with 1% (w/v) uranyl acetate, air-dried, and examined in the electron
microscope. Assembly into regular structures occurred at mildly acidic
pH, in the presence of moderate (0.6–1.1 M) NaCl concentrations. Typi-
cally, the NaCl solutions were buffered with 0.20 M citric acid/KOH
pH 4.9, 0.20 M acetic acid/KOH pH 4.9, or 0.20 M malic acid/KOH
pH 5.5. The temperature at which the experiments were performed was
not critical and ranged between 4 and 37°C.
Electron microscopy and image processing
Images of the specimens were recorded using a Phillips EM420 elec-
tron microscope equipped with a lanthanum boride filament, operated
at 80–100 kV. Micrographs were recorded on Kodak SO-163 photo-
graphic film, at a nominal magnification of 36000x, using a low-dose
unit to reduce electron exposure. The micrographs were digitized on a
Zeiss-SCAI scanner, with a step size of 7 or 14 µm.
The MRC image processing package was used for image analysis.
Defocus values were determined from the spacing of the Thon rings in
the computed Fourier transform of each image. For analysis of the
planar periodic arrays, maxima in the Fourier transform were manually
indexed, and the lattice refined by least-squares methods. Fourier coef-
ficients were then derived directly from the computed transform, by
determining the amplitude and phase at the positions predicted by the
crystallographic reciprocal lattice.
Supplementary material
Supplementary material including a TEM image of RSV CA, a Fourier
transform and projection map is available at http://current-
biology.com/supmat/supmatin.htm.
Accession numbers
The atomic coordinates and raw data of the RSV domain structures
have been deposited with the Protein Data Bank (accession numbers
1EM9 for the N-terminal domain and 1EOQ for the C-terminal domain).
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